Network models incorporating chloride dynamics predict optimal strategies for terminating status epilepticus
Status epilepticus (SE), seizures lasting beyond five minutes, is a medical emergency commonly treated with benzodiazepines which enhance GABA<sub>A</sub> receptor (GABA<sub>A</sub>R) conductance. Despite widespread use, benzodiazepines fail in over one-third of patients, potentially due to seizure-induced disruption of neuronal chloride (Cl<sup>-</sup>) homeostasis. Understanding these changes at a network level is crucial for improving clinical translation. Here, we address this using a large-scale spiking neural network model incorporating Cl<sup>-</sup> dynamics, informed by clinical EEG and experimental slice recordings. Our simulations confirm that the GABA<sub>A</sub>R reversal potential (E<sub>GABA</sub>) dictates the pro- or anti-seizure effect of GABA<sub>A</sub>R conductance modulation, with high E<sub>GABA</sub> rendering benzodiazepines ineffective or excitatory. We show SE-like activity and E<sub>GABA</sub> depend non-linearly on Cl<sup>-</sup> extrusion efficacy and GABA<sub>A</sub>R conductance. Critically, cell-type specific manipulations reveal that pyramidal cell, not interneuron, Cl<sup>-</sup> extrusion predominantly determines the severity of SE activity and the response to simulated benzodiazepines. Leveraging these mechanistic insights, we develop a predictive framework mapping network states to Cl<sup>-</sup> extrusion capacity and GABAergic load, yielding a proposed decision-making strategy to guide therapeutic interventions based on initial treatment response. This work identifies pyramidal cell Cl<sup>-</sup> handling as a key therapeutic target and demonstrates the utility of biophysically detailed network models for optimising SE treatment protocols.
Authors
- Henning Sprekeler (ORCID: https://orcid.org/0000-0003-0690-3553)
- Georgia Ramantani (ORCID: https://orcid.org/0000-0002-7931-2327)
- Christopher Brian Currin (ORCID: https://orcid.org/0000-0002-4809-5059)
- Joseph V. Raimondo (ORCID: https://orcid.org/0000-0002-8266-3128)
- Richard Rosch (ORCID: https://orcid.org/0000-0002-0316-5818)
- Richard J. Burman (ORCID: https://orcid.org/0000-0003-3107-7871)
- Tommaso Fedele (ORCID: https://orcid.org/0000-0001-7574-8062)
Institutions
- University of Zurich (CH)
- University of Oxford (GB)
- King's College Hospital NHS Foundation Trust (GB)
- University Children's Hospital Zurich (CH)
- Bernstein Center for Computational Neuroscience Berlin (DE)
- University College London (GB)
- Technische Universität Berlin (DE)
Publication Details
- Journal
- Neurobiology of Disease
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1016/j.nbd.2025.106966
- Citations
- 1
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.91